Protracted Radiation Exposure Linked to Hematologic Cancer Mortality
By Elana Gotkine HealthDay Reporter
THURSDAY, Oct. 24, 2024 -- Protracted low-dose exposure to ionizing radiation among radiation-monitored workers is associated with mortality due to some hematologic malignancies, according to a study published online in the October issue of The Lancet Hematology.
Klervi Leuraud, Ph.D., from the Institut de Radioprotection et de Sûreté Nucléaire in Fontenay-aux-Roses, France, and colleagues examined the associations between radiation dose and mortality due to hematologic malignancies in a cohort of 309,932 radiation-monitored workers employed for at least one year by nuclear facilities in France, the United Kingdom, and the United States.
The researchers found that a linear model described the association between cumulative dose to red bone marrow, lagged two years, and leukemia (excluding chronic lymphocytic leukemia; excess relative rate per Gy, 2.68), which was not modified by neutron exposure, internal contamination monitoring status, or period of hire. For chronic myeloid leukemia and myelodysplastic syndromes alone or combined with acute myeloid leukemia, positive associations were also seen (excess relative rates per Gy, 9.57, 3.19, and 1.55, respectively). For acute lymphoblastic leukemia or chronic lymphocytic leukemia, no significant association was seen. There was a positive association between radiation dose and multiple myeloma (excess relative rate per Gy, 1.62); minimal evidence of association was seen between radiation dose and non-Hodgkin or Hodgkin lymphoma mortality.
"Studies of people exposed to low doses of radiation add to our understanding of radiation risks at the exposure levels of contemporary concern, and thus can inform radiation protection efforts," the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
AI Models Can Help Predict In-Hospital Mortality in ICU Patients With Lymphoma
FRIDAY, Aug. 29, 2025 -- Machine learning (ML) models predict in-hospital mortality in intensive care unit (ICU) patients with lymphoma, according to a study published online Aug...
Leukemia Stem Cell-Based Method Aids Relapse Prediction in Acute Myeloid Leukemia
FRIDAY, Aug. 29, 2025 -- An assay that uses leukemia stem cells (LSCs) to assess measurable residual disease (MRD) outperforms traditional methods in patients with acute myeloid...
Mortality Up for Children With Leukemia From Lowest SES Neighborhoods
THURSDAY, Aug. 28, 2025 -- Children with acute lymphoblastic leukemia (ALL) from the lowest socioeconomic status (SES) neighborhoods have an increased risk for mortality...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.